Skip to main content
Livermore
Livermore
ZHEN

iTeos Therapeutics, Inc.

ITOSDelisted Aug 29, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001808865

iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.

Q1 2023 vs. Q4 2022

How the institutions holding iTeos Therapeutics, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of ITOS: Q4 2022 compared with Q1 2023
MeasureQ4 2022Of which not filed for Q1 2023Q1 2023Change
Holders1461153+8
Shares36.2M14.5K36.0M−203.9K (−0.6%)
Value$707.3M$282.0K$488.9M−$218.1M (−30.9%)

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held iTeos Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to ITOS in Q1 2023
InstitutionSharesValue% of portfolio
UBS Oconnor LLC69,300$943.2K0.02%
AlphaCentric Advisors LLC63,000$857.4K0.59%
Marshall Wace, LLP55,009$748.7K0.00%
Squarepoint Ops LLC54,115$736.5K0.01%
Cubist Systematic Strategies, LLC46,448$632.2K0.01%
Tekla Capital Management LLC45,735$622.5K0.02%
Boothbay Fund Management, LLC35,652$485.2K0.01%
Caxton Associates LP30,695$417.8K0.07%
Allianz Asset Management GmbH30,179$410.7K0.00%
Profund Advisors LLC22,170$301.7K0.02%
NinePointTwo Capital19,510$265.0K0.10%
Trexquant Investment LP13,933$189.6K0.01%
Group One Trading, L.P.13,679$186.2K0.01%
Gsa Capital Partners LLP13,251$180.0K0.02%
Cornercap Investment Counsel Inc12,557$170.9K0.03%
Dynamic Technology Lab Private Ltd11,856$161.0K0.01%
Point72 Asset Management, L.P.3,620$49.3K0.00%
James Investment Research Inc2,680$36.0K0.00%
Point72 Middle East FZE900$12.2K0.00%
Leonteq Securities AG800$10.9K0.00%
US Bancorp259$3.52K0.00%
Parallel Advisors, LLC164$2.23K0.00%
Fisher Asset Management, LLC102$1.39K0.00%
Massmutual Trust Co FSB83$1.13K0.00%
Allworth Financial LP54$7350.00%

Sold out (17)

Institutions that held iTeos Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of ITOS in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Advisors Preferred, LLC90,973$1.69M
Man Group plc85,756$1.67M
Braidwell LP71,585$1.40M
PFM Health Sciences, LP70,922$1.39M
Ergoteles LLC40,468$790.3K
Exchange Traded Concepts, LLC28,531$557.2K
Alberta Investment Management Corp25,099$490.2K
Oasis Management Co Ltd.24,000$468.7K
Acadian Asset Management LLC23,159$451.0K
Endurant Capital Management LP21,041$410.9K
Zebra Capital Management LLC13,946$272.0K
Worth Venture Partners, LLC12,766$268.5K
Jane Street Group, LLC13,733$268.2K
Quantbot Technologies LP3,438$67.1K
Sutton Wealth Advisors Inc.467$9.12K
Parkside Financial Bank & Trust76$1.48K
Glassman Wealth Services9$176

Not filed for Q1 2023 yet (1)

Institutions that held iTeos Therapeutics, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ITOS in Q4 2022 that haven't filed for Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Comerica Bank14,520$282.0K